US 10239870
Dopamine D3 receptor antagonists
granted A61PA61P25/12A61P25/18
Quick answer
US patent 10239870 (Dopamine D3 receptor antagonists) held by Indivior UK Limited expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61P, A61P25/12, A61P25/18, A61P25/30, A61P43/00